Effects of inflammatory cells on neuronal M2 muscarinic receptor function in the lung

Life Sciences

Volumn 64, Issue 6-7, 1999, Pages 449-455

  Fryer, Allison D ^a   Adamko, Darryl J ^a   Yost, Bethany L ^a   Jacoby, David B ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

Asthma; Eosinophils; Hyperreactivity; Interferon

Indexed keywords

ACETYLCHOLINE; GAMMA INTERFERON; MAJOR BASIC PROTEIN; MUSCARINIC M2 RECEPTOR; SIALIDASE;

ACETYLCHOLINE RELEASE; ASTHMA; BREATHING MUSCLE; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CONFERENCE PAPER; GENE EXPRESSION; HUMAN; INFLAMMATORY CELL; INTERFERON PRODUCTION; NONHUMAN; RECEPTOR AFFINITY; SMOOTH MUSCLE CONTRACTION; VIRUS INFECTION;

ACETYLCHOLINE; ANIMALS; ASTHMA; HUMANS; INFLAMMATION; LEUKOCYTES; LUNG; NEURONS; RECEPTOR, MUSCARINIC M2; RECEPTORS, MUSCARINIC; RESPIRATORY HYPERSENSITIVITY; VIRUS DISEASES;

ANIMALIA; BRONCHUS;

EID: 0033534395     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00587-6     Document Type: Conference Paper

References (49)

1. P. Jeffery, A. Wardlaw, F. Nelson, J. Collins and A. Kay, Am Rev Respir Dis 140 1745-1753 (1989).
2. A. Vathenen, A. Knox, A. Wisniewski and A. Tattersfield, Am Rev Respir Dis 143 1317-1321 (1991).
3. D.W. Empey, L.A. Laitinen, L. Jacobs, W.M. Gold and J.A. Nadel, Am. Rev. Respir. Dis. 113 523-527 (1976).
4. R.F. Lemanske, E.C. Dick, C.A. Swensen, R.F. Vrtis and W.W. Busse, J. Clin. Invest. 83 1-10 (1989).
5. J.A. Golden, J.A. Nadel and H.A. Boushey, Am. Rev. Respir. Dis. 118 287-294 (1978).
6. R. Costello and A. Fryer, Asthma, P. Barnes and M. Grunstein (Eds), Lippincott-Raven, Philadelphia pp965-984 (1997).
7. H. Colebatch and F. Halmagyi, J Appl Physiol 18 881-887 (1963).
8. J. Nadel and P. Barnes, Ann Rev Med 35 451-67 (1984).
9. N. Molfino, A. Slutsky and G. Julia-Serda, Am Rev Respir Dis 148 1238-43 (1993).
10. G. Cropp, Am Rev Respir Dis 112 599-605 (1975).
11. M. Cavanaugh and D. Cooper, Am Rev Respir Dis 114 517-524 (1976).
12. M.I. Ullah, G.B. Newman and K.B. Saunders, Thorax 36 523-529 (1981).
13. A.D. Fryer and J. Maclagan, Br. J. Pharmacol. 83 973-978 (1984).
14. A. Fryer, Asthma and Rhinitis, Eds: W. Busse and S. Holgate. Blackwell Scientific Publications, Boston. pp691-703 (1994).
15. P. Minette and P.J. Barnes, J. Appl. Physiol. 64 2532-2537 (1988).
16. R. Ten Berge, J. Zaagsma and A. Roffel, Am J Respir Crit Care Med 154 43-49 (1996).
17. A.D. Fryer and D.B. Jacoby, Br J Pharmacol 102 267-271 (1991).
18. A.D. Fryer and M. Wills-Karp, J. Appl. Physiol. 71 2255-2261 (1991).
19. A. Schultheis, D. Bassett and A. Fryer, J. Appl. Physiol. 76 1088-1097 (1994).
20. L.E. Ayala and T. Ahmed, Chest 96 1285-1291 (1989).
21. M. Okayama, T. Shen, J. Midorikawa, J. Lin, H. Inoue, T. Takishima and K. Shirato, Am J Respir Crit Care Med 149 76-80 (1994).
22. J.E. Mills and J.G. Widdicombe, Br. J. Pharmacol. 39 724-731. (1970).
23. D. Sheppard, J. Epstein, M.J. Holtzman, J.A. Nadel and H.A. Boushey, J. Appl. Physiol. 53 169-174 (1982).
24. K. Belmonte, A. Fryer and R. Costello, J Appl Physiol In press. (1998).
25. D. Jacoby and E. Wagner, Am J Respir Critical Care Med 153 A628 (1996).
26. L.M. Gambone, C.L. Elbon and A.D. Fryer, J. Appl. Physiol. 77 1492-1499 (1994).
27. A.D. Fryer, K.A. Yarkony and D.B. Jacoby, Br. J. Pharmacol. 112 588-594 (1994).
28. C.L. Elbon, D.B. Jacoby and A.D. Fryer, Am. J. Respir. Cell Mol Biol. 12 320-328 (1995).
29. A.D. Fryer, R.W. Costello, B.Y. Yost, R.R. Lobb, T.F. Tedder, A.S. Steeber and B.S. Bochner, J. Clin. Invest. 99 2036-2044 (1997).
30. C.M. Evans, D.B. Jacoby, G.J. Gleich, A.D. Fryer and R.W. Costello, J Clin Invest. 100 2254-2262 (1997).
31. R. Costello, B. Schofield, G. Kephart, G. Gleich, D. Jacoby and A. Fryer, Am J Physiol 273 L93-L103 (1997).
32. J. Hu, S.-Z. Wang, C. Forray and E.E. El-Fakahany, Mol. Pharmacol. 42 311- 324 (1992).
33. D.B. Jacoby, G.J. Gleich and A.D. Fryer, J. Clin. Invest. 91 1314-1318 (1993).
34. D. Jacoby, G. Gleich and A. Fryer, Am. J. Respir. Crit. Care Med. 151 A821 (1995).
35. A.D. Fryer and D.B. Jacoby, J. Clin. Invest. 90 2292-2298 (1992).
36. A. Fryer, Y. Huang, G. Rao, D. Jacoby, Mancilla, E, R. Whorton, C. Piantadosi, T. Kennedy and J. Hoidel, J Pharmacol Expt Thera 282 208-219 (1997).
37. C. Evans, D. Jacoby and A. Fryer, Am J Respir and Crit Care Med 157 A599 (1998).
38. R. Costello, A. Fryer, K. Belmonte and D. Jacoby, Br. J. Pharmacol 124 267-276 (1998).
39. B. Yost, G. Gleich and A. Fryer, Am J Respir and Crit Care Med 157 A820 (1998).
40. J.J. Walsh, L.F. Dietlein, F.N. Low, G.E. Burch and W.J. Mogabgab, Arch. Int. Med. 108 376-388 (1960).
41. A.R. Pecoud, S. Ruddy and D.H. Conrad, J. Immunol. 126 1624-1629 (1981).
42. N. Baumgarth, B. L, D. Jackson and A. Kelso, J Virol. 68 7575-7581 (1994).
43. D. Jacoby, H. Xiao, N. Lee and A. Fryer, J Clin Invest 102 242-248 (1998).
44. D.A.D. Fryer, E.E. El-Fakahany, and D.B. Jacoby, Eur J Pharmacol 181 51-58 (1990).
45. S. Johnston, P. Pattemore, G. Sanderson, S. Smith, F. Lampe, L. Josephs, P. Symington, S. Otoole, S. Myint, D. Tyrrell and S. Holgate, Br Med J 310 1225-1229 (1995).
46. E. Frigas, D.A. Loegering, G.O. Solley, G.M. Farrow and G.J. Gleich, Mayo Clin Proc 56 345-353 (1981).
47. R. Garofalo, J. Kimpen, R. Welliver and P. Ogra, J Pediatr 120 28-32 (1992).
48. A. Coyle, F. Erard, C. Bertrand, S. Walti, H. Pircher and G G. Le, J Exp Med 181 1229-1233 (1995).
49. D. Adamko, T. Elwood, A. Fryer and D. Jacoby, Am J Respir and Crit Care Med 157 A242 (1998).